Brazilian Rare Earths (ASX:BRE) has seen significant price momentum recently, with shares up 8.9% after announcing ultra-high-grade rare earth discoveries exceeding 15% TREO at its Monte Alto project in Brazil's Bahia region . The company also secured a Trial Mining Licence from Brazil’s National Mining Agency, enabling limited production for customer evaluations and metallurgical testing, which has driven a 22% rise over the past 30 days and 31.68% year-to-date at around A$5.03 .
Trading activity has intensified alongside these developments, reflecting heightened investor interest in BRE's potential as a non-Chinese rare earth supplier. Year-over-one returns stand at 122.57%, with short-term gains of 2.9% weekly and 15.8% monthly, signaling strong momentum despite A$42.06 million in losses against minimal revenue .
Market sentiment is predominantly positive, fueled by Monte Alto's globally significant grades and near-term catalysts like bulk ore shipments and a Camaçari pilot plant. However, analysts note risks in funding, execution by new management, and scaling a commercial flowsheet . Simply Wall St's DCF model suggests a fair value of A$37.62, implying substantial undervaluation, though the P/B ratio at 8.7x exceeds peers, questioning if growth is overanticipated . Community fair value views range from A$0.77 to A$7.67 .
In recent months, BRE's price may have been influenced by broader Brazilian rare earth sector buzz, including USA Rare Earth's $2.8B acquisition of Serra Verde to challenge China's monopoly and heightened focus on supply chain diversification . Quarterly updates highlight accelerating projects among ASX-listed Brazil explorers, while illegal mining in the Amazon underscores Brazil's vast reserves (19-23% global) . BRE also announced its 2026 AGM in Sydney to review 2025 performance and governance .